Streetbeat News

Stock Prices

DIS

TSLA

Tesla, Inc. (TSLA) surpassed Disney Co. (DIS) in annual revenue for 2023, reporting $96.77 billion, a 19% increase over the previous year, compared to Disney's $88.90 billion. Despite this, Tesla's stock faced challenges after missing EPS expectations for two consecutive quarters and lowering its 2024 volume growth forecast. Tesla's market cap dropped significantly in January, but shares recovered slightly on Monday. Analysts have mixed views, with some adjusting their outlooks and suggesting strategies for recovery, while others express concern over the near-term future of the stock.

Portfolio Pulse from Shanthi Rexaline

January 30, 2024 | 8:11 am

AMZN

GOOG

GOOGL

IRBT

MSFT

PFE

Market sentiment improved slightly with the CNN Money Fear and Greed index indicating 'Extreme Greed'. The S&P 500 hit a new record ahead of major tech earnings and the Fed's interest-rate decision. iRobot shares fell 8.8% after terminating its acquisition agreement with Amazon. The Dallas Fed's manufacturing index dropped significantly. The Dow Jones, S&P 500, and Nasdaq closed higher. Investors anticipate earnings from Microsoft, General Motors, Alphabet, and Pfizer.

Portfolio Pulse from Avi Kapoor

January 30, 2024 | 8:03 am

FFIV

GOOG

MSFT

SMCI

Investors are watching Alphabet, Microsoft, F5, Super Micro Computer, and General Motors as U.S. stock futures trade lower. Alphabet is expected to report earnings with an EPS of $1.59 and revenue of $85.33 billion. F5 reported better-than-expected Q1 results, causing a 9.2% stock increase. Microsoft is anticipated to post an EPS of $2.78 and revenue of $61.10 billion. Super Micro Computer released positive Q2 results, leading to a 10.5% stock jump. General Motors is expected to report earnings with an EPS of $3.56 and revenue of $4.98 billion.

Portfolio Pulse from Avi Kapoor

January 30, 2024 | 7:55 am

BTCUSD

ETHUSD

SOLUSD

Anthony Scaramucci, founder of Skybridge Capital and former White House official, criticized Senator Elizabeth Warren's stance on cryptocurrency, calling her 'absolutely repulsive and hypocritical.' He labeled Warren and SEC's Gary Gensler as the 'axis of regulatory evil' for their approach to crypto regulation. Scaramucci believes Warren's perspective could harm the unbanked and those outside the U.S. who can't trust their currencies or banks. He also expressed bullish views on Bitcoin, predicting a significant price increase post the upcoming halving event. Scaramucci reported Skybridge Capital's cryptocurrency investments, including Bitcoin, Ethereum, and Solana, have seen a 130% rise.

Portfolio Pulse from Mehab Qureshi

January 30, 2024 | 7:36 am

TPST

Tempest Therapeutics has announced significant progress in liver cancer treatment, presenting promising efficacy and safety data at the ASCO Annual Meeting 2024. This breakthrough could potentially improve treatment options for liver cancer patients.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 7:23 am

SIDU

Sidus Space, Inc. (NASDAQ:SIDU) has priced an underwritten public offering of 1,251,700 Class A shares (or Pre-funded Warrants) at $4.50 each, aiming to raise approximately $5.63 million before underwriting discounts and offering expenses. All offered securities are being sold by the Company.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 7:11 am

AAPL

META

Gene Munster of Deepwater Asset Management compared Meta Platforms Inc.'s competition with Apple Inc. in the AR/VR headset market to the past rivalry between BlackBerry Ltd and Apple in the smartphone market. Munster suggested that Meta might face a similar fate to BlackBerry, which lost its market dominance to Apple's innovative products. Apple is set to launch its Vision Pro mixed-reality headset, while Meta has already released its Quest 3 VR headset. Munster believes that Apple's entry into the market could validate Zuckerberg's vision but also poses a significant threat to Meta, echoing the past when Apple overtook BlackBerry.

Portfolio Pulse from Ananya Gairola

January 30, 2024 | 7:11 am

CNSP

CNS Pharmaceuticals has announced a public offering of 13,333,334 common shares at $0.30 per share, along with Series A and Series B Warrants to purchase an equal number of shares. The warrants are exercisable immediately upon issuance and expire in five years and eighteen months, respectively. The offering is expected to close on or about February 1, 2024, subject to customary closing conditions.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 7:05 am

AMC

JBT

NOC

On CNBC's 'Mad Money,' Jim Cramer advised against investing in AMC Entertainment Holdings Inc. (NYSE:AMC), citing a decline in moviegoers and the stock's poor performance. Instead, he recommended Northrop Grumman Corporation (NYSE:NOC) and John Bean Technologies Corporation (NYSE:JBT), praising NOC's current price and JBT's position in the industrial food sector. AMC's short percent of float has increased, indicating bearish sentiment, despite a revenue increase in Q3.

Portfolio Pulse from Benzinga Neuro

January 30, 2024 | 7:03 am

AAPL

AMZN

GOOG

GOOGL